Avalo Therapeutics (AVTX) Stock Chart & Stock Price History $4.88 +0.01 (+0.10%) As of 01:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avalo Therapeutics Stock Price Performance The Avalo Therapeutics (AVTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 58.00%, with a year-to-date return of -34.25%. In the past month, the stock has increased 32.74%, reflecting recent market activity. As of the latest close, Avalo Therapeutics traded at $4.88 with a market cap of $52.84 million and volume of 46,938 shares. Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+19.15%1 Month Performance+32.74%3 Month Performance-34.16%Year-To-Date Performance-34.25%1 Year Performance-58.00% AVTX Stock Chart for Friday, June, 13, 2025 AVTX Chart by TradingView Avalo Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$4.71$4.88+3.61%$4.95$4.6246,938 shs$52.84 million06/11/2025$4.82$4.71-2.28%$4.98$4.5938,289 shs$51 million06/10/2025$4.56$4.82+5.70%$5.00$4.60129,030 shs$52.19 million06/09/2025$4.10$4.56+11.22%$4.69$4.20197,319 shs$49.38 million06/06/2025$4.33$4.10-5.31%$4.49$4.0689,023 shs$44.40 million06/05/2025$4.35$4.33-0.46%$4.50$4.15495,961 shs$46.89 million06/04/2025$4.40$4.35-1.14%$4.55$4.1349,558 shs$47.10 million06/03/2025$4.35$4.40+1.15%$4.48$4.2769,357 shs$47.64 million06/02/2025$3.95$4.35+10.13%$4.71$3.93139,388 shs$47.10 million05/30/2025$3.72$3.95+6.18%$4.00$3.6157,176 shs$42.77 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$3.59$3.72+3.62%$3.82$3.5847,674 shs$40.28 million05/28/2025$3.62$3.59-0.83%$3.70$3.4333,432 shs$38.87 million05/27/2025$3.75$3.62-3.47%$3.87$3.5862,597 shs$39.20 million05/26/2025$3.75$3.75$4.03$3.6729,521 shs$40.61 million05/23/2025$3.91$3.75-4.09%$4.03$3.6729,521 shs$40.61 million05/22/2025$3.79$3.91+3.17%$3.92$3.6779,586 shs$42.34 million05/21/2025$4.10$3.79-7.56%$4.30$3.7726,836 shs$41.04 million05/20/2025$4.00$4.10+2.50%$4.41$3.89180,478 shs$44.40 million05/19/2025$3.91$4.00+2.30%$4.10$3.7275,890 shs$43.31 million05/16/2025$3.86$3.91+1.30%$4.22$3.8689,190 shs$42.34 million05/15/2025$3.60$3.86+7.22%$3.86$3.5331,251 shs$41.80 million05/14/2025$3.68$3.60-2.17%$3.76$3.3939,484 shs$38.98 million05/13/2025$4.00$3.68-8.00%$4.00$3.6732,716 shs$39.85 million05/12/2025$4.06$4.00-1.48%$4.29$3.8368,230 shs$43.31 million Related Companies Nuvectis Pharma Stock Chart Inhibrx Stock Chart ProQR Therapeutics Stock Chart Monopar Therapeutics Stock Chart Eledon Pharmaceuticals Stock Chart Esperion Therapeutics Stock Chart Voyager Therapeutics Stock Chart Journey Medical Stock Chart DiaMedica Therapeutics Stock Chart Organigram Stock Chart Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
